Table 1 Mechanism and function of BRDs in immunity and disease
BET | Expression | Disease model | Cell type | Treatment | Transcription factor | Binding sites in histones | Target genes | BETi | Refs |
---|---|---|---|---|---|---|---|---|---|
Infectious diseases | |||||||||
Bacterial infection | |||||||||
BRD2 BRD4 | N/A | Gram-negative bacterial infection | Mouse SIM-A9 microglial cell line, mouse primary astrocytes | LPS | N/A | N/A | NOS2, COX2, IL1B, TNF, IL6, CCL2, MMP9, SERPINE1 | dBET1, JQ1 | |
BRD2 BRD3 BRD4 | N/A | Endotoxemia | Mouse bone marrow derived macrophages (BMDMs) | LPS | RELA, IRF4, IRF8 | H3Ac, H4K5Ac, H4K8Ac, H4K12Ac, H4Ac | TNF, IL6, IFNB1, CCL2, IL1B, IL12A, CXCL9, CCL12 | I-BET, JQ1 | |
BRD4 | N/A | Sepsis, group B Streptococcus (GBS) infection | Mouse BMDMs | GBS, LPS, cecal ligation puncture | RELA | N/A | IL6, IL1A, IL12B, CXCL9, IL23A | N/A | |
BRD2 BRD4 | Upregulation | Pseudomonas aeruginos infection | Human bronchial epithelial cells | IL17 | N/A | N/A | IL17A, IL22, CXCL1, CXCL5, CXCL8, CCL2, CSF3, IL6 | CPI-203 | |
BRD2 BRD3 BRD4 | N/A | Heat-killed L. monocytogenes infection | Mouse BMDMs | IFNB | RELA | N/A | NOS2, IL6, IL1RN | JQ1 | |
Virus infection | |||||||||
BRD4 | Upregulation | RNA virus (respiratory syncytial virus infection) | Human small airway epithelial cells, nonciliated secretoglobin (Scgb1a1)-expressing bronchiolar epithelial cells | Poly(I:C) | RELA, IRF1, IRF7, IRF3 | H3K122Ac | IL6, ISG54, CIG5, RANTES, FN1, COL1A, MMP9, VIM, ACTA2, HEXIM1, KC, CSF3, CSF2, CXCL1, CXCL2, CXCL8, CCL2 | ZL0513, ZL0516, ZL0420, ZL0454, JQ1 | |
BRD4 | No change | Virus infection | Pig PK15 cells | Pseudorabies virus, herpes simplex virus, ectromelia virus, etc. | IRF3, RELA | H3K9, H3K27, H4K8, H4K12, H4K16 | IL1B, IFNB, ISG15 | JQ1, OTX-015, I-BET 151 | |
BRD4 | Downregulation | HIV-1 infection | Memory CD4+ T cells | N/A | N/A | N/A | N/A | N/A | |
BRD4 | N/A | HIV-1 infection | J-Lat A2 cell line | N/A | N/A | N/A | HIV | JQ1 | |
BRD3 | Downregulation | Virus infection | Mouse macrophage cell line RAW 264.7 | Sendai virus, vesicular stomatitis virus, herpes simplex virus | IRF3 | H3/H4 | IFNB1 | N/A | |
Fungi and parasitic infection | |||||||||
BRD2 BRD3 BRD4 | N/A | Candida albicans and Aspergillus fumigatus infection | Whole blood cells, peripheral blood mononuclear cells, monocytes | N/A | N/A | H3K4Me3, H3K27Ac | TNF, IL6 | I-BET151, JQ1 | |
BRD2 | Upregulation | Plasmodium yoelii and Toxoplasma gondii-infected liver | N/A | N/A | N/A | N/A | TNF, IFNG | N/A | |
BRD2 BRD3 BRD4 | N/A | Schistosoma japonicum infection | Human Th17 cells | N/A | RORC | N/A | IL17, IL21, CSF2 | JQ1 | |
Non-infectious diseases | |||||||||
Cancer | |||||||||
BRD4 | Upregulation | Renal cancer | Human renal cell carcinoma cell lines | LPS | RELA | H3K27Ac | CXCL1, CXCL8, CXCR2, CSF2, CSF3, NLRP3 | JQ1 | |
BRD4 | N/A | Prostate cancer | Human prostate cancer cell lines (DU145, PC3) | N/A | N/A | N/A | CD274, HLA-A, HLA-C, IFNG | JQ1 | |
BRD4 | N/A | Pancreatic cancer | Pancreatic cancer cell lines (PANC-1, BxPC-3, MIA PaCa-2), pancreatic stellate cells | IFNG | IRF1 | N/A | CD274 | JQ1, IBET | |
BRD2 BRD3 BRD4 | N/A | Pancreatic cancer | Aspc-1, PANC-1, CAPAN-1 cells, mouse pancreatic cancer cell lines PanAsc 2159 and Panc 1343, RAW 264.7 | IFNG, LPS | STAT3 | N/A | IL6, CCL2, CSF2 | JQ1, I-BET 762 | |
BRD3 | N/A | Gastric adenocarcinoma | Microsatellite instability high gastric cancer cells | N/A | N/A | N/A | CD274 | N/A | |
BRD2 BRD3 BRD4 | N/A | A549 tumor-bearing nude mice, neuroblastoma | N/A | N/A | N/A | N/A | CD274 | JQ1 | |
BRD4 | N/A | Triple-negative breast cancer, hepatocellular carcinoma | Peripheral blood mononuclear cells, monocytes | N/A | CEBPB | H3K27Ac | CD274 | JQ1, I-BET762 | |
BRD4 | N/A | Triple-negative breast cancer | Human breast cancer cell line | IL6 | N/A | N/A | JAG1 | JQ1 | |
BRD2 BRD4 | Upregulation | Malignant pleural mesothelioma | Human primary malignant pleural mesothelioma cells | N/A | N/A | N/A | CD274, PDCD1 | JQ1, OTX015 | |
BRD2 | N/A | Melanoma | Human melanoma cell lines (Mel-RMu, SK-Mel28, Mel-RM, Mel-JD, Me1007) | N/A | RELA | N/A | IL6, IL8, VEGF, CXCL10, RANTES | I-BET151 | |
BRD2 BRD3 BRD4 | N/A | Human Ty-82 xenografts | Ty-82, SKOV3, A549, MDA-MB-231 cells | N/A | N/A | H3K27Ac | IDO1 | ABBV-075, JQ1, OTX015 | |
BRD4 | Upregulation | Breast cancer with T-bet+ tumor-infiltrating T lymphocytes | T-bet+ TILs | N/A | N/A | N/A | JAG1 | N/A | |
BRD4 | Upregulation | Mucoepidermoid carcinoma | Human mucoepidermoid carcinoma cells | N/A | RELA | N/A | N/A | I-BET762 | |
BRD2 BRD3 BRD4 | N/A | Neuroblastoma | NK cells | N/A | MYC, TP53 | N/A | ULBP1, ULBP3, PVR, NECTIN2 | JQ1 | |
BRD2 BRD3 BRD4 | N/A | Primary effusion lymphoma | N/A | N/A | RELA | N/A | IL6 | JQ1 | |
BRD2 BRD3 BRD4 | N/A | Myeloproliferative neoplasms | JAK2V617F-positive SET-2 cells | N/A | RELA | H3K27Ac | CCL2, CCL3, CCL4, CCL5, IL10, IL6, IL13, CXCL9, CSF3, II15, CXCL10, II1A, CXCL2, CXCL5 | JQ1 | |
BRD4 | N/A | Multiple myeloma | Human myeloma cell lines (SKO-007(J3), U266, ARP-1, RPMI-8226), human multiple myeloma cell line (JJN-3) | N/A | MYC | N/A | MICA | ARV-825 (PROTAC), JQ1, I-BET151 | |
Cardiovascular diseases | |||||||||
BRD4 | Upregulation | Pathological cardiac hypertrophy | Neonatal mouse cardiomyocytes | Aortic banding, angiotensin-II | RELA | N/A | TNF, IL1B | N/A | |
BRD4 | Upregulation | Pulmonary arterial hypertension | Human microvascular endothelial cells, smooth muscle cells | N/A | FOXM1 | N/A | FOXM1, PLK1, IL8, MCP1, CCL5 | RVX208 | |
BRD2 BRD3 BRD4 | N/A | Pulmonary arterial hypertension | Human pulmonary microvascular endothelial cells | N/A | RELA | N/A | IL6, IL8 | JQ1 | |
BRD2 BRD3 BRD4 | N/A | Cardiovascular disease | Human monocytic cell line (THP-1), human umbilical vein vessel endothelial cells, human artery endothelial cells | TNF, LPS, IL1B | RELA | N/A | VCAM1, CCL2, IL8, SELE, IL1B | Apabetalone, MZ-1 | |
BRD2 BRD3 BRD4 | N/A | Vascular inflammation | Human umbilical vein vessel endothelial cells | TNF, LPS | RELA | N/A | ICAM1, VCAM1, SELE | JQ1 | |
BRD4 | Upregulation | Hypertension | Rat vascular smooth muscle cells | Angiotensin II | JUN, RELA, STAT1, CDX2, FOXL1, LIN54, ETS1 | H3K27Ac | ESM1, SPRY2, TGIF1, FST, FGF2, EGR2, FLT, FOXP1 | JQ1 | |
BRD2 BRD3 BRD4 | N/A | Heart failure (prolonged pressure overload, massive anterior myocardial infarction) | Human induced pluripotent stem cell-derived cardiomyocytes | ET1 | RELA, JUN, STAT1 | N/A | NPPB, CTGF | JQ1 | |
BRD2 BRD4 | Upregulation | Acute myocardial infarction | N/A | N/A | N/A | N/A | TLR4, TRAF6, RELA, CRP, IL6 | JQ1 | |
BRD4 | N/A | Atherogenesis | Human umbilical vein vessel endothelial cells | TNF | RELA | H3K27Ac | VCAM1, SOX18, CCL2 | JQ1 | |
Respiratory diseases | |||||||||
BRD4 | Upregulation | Chronic obstructive pulmonary disorder | Human pulmonary microvascular endothelial cells | Cigarette smoke extract | N/A | N/A | IL6, IL8, TNF | N/A | |
BRD2 BRD3 BRD4 | No change | Chronic obstructive pulmonary disorder | Alveolar macrophages | LPS | N/A | N/A | IL6, CSF2 | JQ1 | |
BRD4 | N/A | Asthma | Primary human small airway epithelial cells | Cat dander extract | RELA | H3K122Ac | COL1, FN1, ZEB1, SNAI1, VIM, IL6 | ZL0454 | |
BRD2 BRD3 BRD4 | N/A | Asthma | CD4+ T cells, human bronchial epithelial cells | Cockroach allergen extract | N/A | N/A | IL4, IL17A, RORC, IL23R | JQ1 | |
BRD4 | N/A | Asthma | Asthmatic airway smooth muscle cells | FCS, TGFB | N/A | N/A | IL6, IL8 | JQ1, I-BET762 | |
BRD2 BRD3 BRD4 | N/A | Neutrophil-dominant allergic airway disease | CD4 + CD62L + naïve T cells | IL23, TGFβ, IL6, anti-IL4, anti-IFNG | N/A | N/A | IL1A, IL1B, IL2, IL6, IL10, IL12B, IL13, IL17A, CCL11, CSF3, CXCL1, CCL4, CCL5 | CPI-203 | |
BRD4 | N/A | Pulmonary fibrosis | Lung fibroblasts | Bleomycin | N/A | H4K5Ac | IL6 | JQ1 | |
Neurological diseases | |||||||||
BRD2 | Upregulation | Parkinson’s disease | Mouse primary microglial cells | Alpha-synuclein (αSynAgg) | STAT3 | N/A | ACOD1, IFIT1, PYHIN, CDC123, SOD1, GRN | N/A | |
BRD2 BRD3 BRD4 | N/A | Systemic sclerosis | Human monocytes of systemic sclerosis patients | N/A | STAT1, STAT2, IRF | H3K27Ac | MX1, CMPK2 | JQ1 | |
BRD4 | Upregulation | Cerebral ischemia/reperfusion injury | Mouse astrocytes, microglial BV2 cells | Oxygen-glucose deprivation/reperfusion | RELA | N/A | IL6, IL1B, IL18, TNF | JQ1 | |
BRD2 BRD3 BRD4 | N/A | Spinal cord injury | BMDMs | LPS | N/A | N/A | IL6, IL1B, TNF, IL4, IL13 | JQ1 | |
BRD2 BRD3 BRD4 | No change | Spinal cord injury | Primary cerebellar granule neurons, astrocytes, oligodendrocytes, microglias | IL1B, TNF | N/A | N/A | IL6, IL1B, CCL5, CCL2, CXCL10, TNF | JQ1 | |
BRD2 | Upregulation | Neuronal damage after deep hypothermic circulatory arrest | Mouse microglial BV2 cells, human neuroblastoma SH-SY5Y cells | Oxygen-glucose deprivation | RELA | N/A | TNF, IL5, IL10, IL13 | JQ1 | |
BRD2 BRD3 BRD4 | N/A | Autoimmune encephalomyelitis | N/A | N/A | N/A | N/A | IL6, IL17, CCL2, CSF2, IFNG, TNF | RVX-297 | |
BRD2 BRD3 BRD4 | N/A | Alzheimer’s disease | N/A | N/A | N/A | N/A | IL1B, IL6, TNF, CCL2, NOS2, PTGS2 | JQ1 | |
Kidney diseases | |||||||||
BRD4 | N/A | Experimental renal damage | Human renal proximal tubular epithelial cells (HK2) | Nephrotoxic serum, TNF | RELA | N/A | IL6, CCL2, CCL5 | JQ1 | |
BRD2 BRD3 BRD4 | N/A | Stage 4 or 5 chronic kidney disease | N/A | N/A | N/A | N/A | IL6, PAI1, OPN | Apabetalone | |
BRD4 | Upregulation | Lupus nephritis | N/A | N/A | N/A | N/A | IL1B, IL6, IL17, IL10, INFG | JQ1 | |
BRD4 | N/A | HIV-associated kidney disease | Human primary renal tubular epithelial cells | TNF, HIV | RELA | H3K9Ac, H3K18Ac, H3K4me3, H3K27me3 | IL1A, IL1B, LTA, LTB, CCL2, CCL3, CCL20, CXCL3, CXCL11, CCL2, CCL20, IL8 | MS417 | |
Digestive diseases | |||||||||
BRD4 | Upregulation | Acute liver injury | Mouse Kupffer cells | Listeriolysin-O | RELA | Â | TNF, IL6, IL1B, IL18, CCL2, CCL8 | JQ1 | |
BRD4 | N/A | Colitis | Mouse intestinal epithelial cells | Dextran sulfate sodium | RELA | H3K9Ac | TNF, IL1B | N/A | |
BRD4 | N/A | Colitis | Th17 cells | N/A | N/A | H4K5Ac, H4K8Ac | IL17, IFNG, IL21, IL22, RORC, TBX21, IL6, GATA3 | MS402 | |
BRD2 BRD3 BRD4 | N/A | Colitis | Mouse BMDCs, human monocyte-derived DCs | LPS | N/A | N/A | IL6, IL12B, IL10 | I-BET151 | |
BRD2 BRD3 BRD4 | N/A | Non-alcoholic fatty liver disease, liver fibrosis | N/A | N/A | N/A | N/A | IFNG, CCL2, TNF, RSAD2, LY6A, CD4, CD7, CXCL10, STAT1, CCL5 | I-BET151 | |
BRD2 BRD3 BRD4 | N/A | Acute pancreatitis | N/A | N/A | N/A | N/A | IL6, IL10, CCL2, CXCL1 | I-BET762 | |
Metabolic diseases | |||||||||
BRD2 BRD4 | N/A | Cancer cachexia | N/A | N/A | FOXO3 | N/A | IL6, TNF, IL1B, PTHLH | JQ1 | |
BRD2 BRD4 | N/A | Obesity, insulin resistance, diabetes | INS-1 cells, mouse adipocytes (3T3-L1) | TNF | PPARG, RELA | N/A | INS, TNF, CXCL2, IL1B, IL6, CCL2 | JQ1 | |
BRD2 BRD3 BRD4 | N/A | Type 1 diabetes | Pancreatic macrophages, β cells | LPS | RELA | N/A | CCL2, CCL5, CXCL1, CXCL2, IFNB1, IL1A, IL1B, NFKBIA, TNF, TNFAIP3, TNFRSF9, VCAM1, CXCL9, IL12B, IL6, MX1, MX2, RSAD2 | I-BET151 | |
Osteoarthritis | |||||||||
BRD4 | Upregulation | Intervertebral disc degeneration | Nucleus pulposus cells | TNF, advanced glycation end products | RELA | N/A | NLRP3, CASP1, MMP13 | JQ1 | |
BRD4 | N/A | Acute gouty arthritis | Human monocytic cell line (THP-1) | Monosodium urate | RELA | N/A | IL1B | Benzo[cd]indol-2(1H)-ones, Pyrrolo[4,3,2- dequinolin-2(1H)-ones | |
BRD4 | Upregulation | Periprosthetic osteolysis | Mouse macrophage RAW264.7 cells | Titanium particles | RELA | N/A | TNF, IL1B, IL6 | JQ1 | |
BRD3 BRD4 | N/A | Osteoarthritis | Human chondrosarcoma cells (SW1353) | IL1B, TNF | Â | H4K5Ac, H4K8Ac, H4K12Ac | MMP1, MMP3, MMP13, ADAMTS4 | I-BET151 | |
BRD2 BRD3 BRD4 | N/A | Failure of bone healing | C2C12 and MC3T3-E1 cell lines, BMDMs | TNF | RUNX2, SP7 | N/A | ALP, RUNX2, SP7 | N-methylpyrrolidone and N, N-dimethylacetamide, JQ1 | |
BRD4 | Upregulation | Articular cartilage of osteoarthritis | Human chondrocyte cell line sw1353 cells | IL1B | RELA | H3K27Ac | HMGB1, IL1B | JQ1 | |
BRD2 BRD3 BRD4 | Upregulation | Rheumatoid arthritis | Human rheumatoid arthritis fibroblast-like synoviocytes | TNF, IL1B | JUN, RELA | N/A | TNF, IL1B, IL6, IL8, IL17, IL18, MMP1, MMP3, MMP13 | JQ1, I-BET151 | |
Others | |||||||||
BRD2 BRD3 BRD4 | Upregulation | Spontaneous preterm birth | Myometrial cells, amnion epithelial and mesenchymal cells | LPS, IL1B | RELA | N/A | IL6, CCL2, CXCL1, CXCL8 | JQ1 | |
BRD4 | Upregulation | Preeclampsia | Primary trophoblasts, human umbilical vein vessel endothelial cells | TNF | N/A | N/A | IL6, CXCL8, CCL2, CXCL1, FLT1 | N/A | |
BRD4 | N/A | Autoimmune uveitis (EAU) | Human CD4 + T cells, human Th17-polarized cells | Anti-CD3/CD28 | RORC | N/A | IL17A, IL22, RORC, IL10 | GSK151, JQ1 | |
BRD2 | Upregulation | Inherited retinal degeneration | Mouse primary microglias | LPS | N/A | N/A | TNF, CCL2, IL1B, IL6, RANTES | JQ1, RVX-208 | |
BRD2 BRD3 BRD4 | N/A | Age-related macular degeneration | Human retinal pigment epithelial cell line (ARPE-19) | Etoposide | RELA | N/A | IL6, IL8 | JQ1, PFI-1, I-BET151 | |
BRD2 | N/A | Psoriasis | Primary human keratinocytes, HS27 dermal fibroblasts | IL17A, TNF, IL22 | RELA | Â | IL8, CXCL1, CXCL2, CXCL6, CXCL8, GCSF, CCL20 | JQ1, I-BET151 | |
BRD2 BRD3 BRD4 | N/A | Psoriasis-like inflammation | N/A | Imiquimod | RORC | N/A | IL17A, IL22 | JQ1 | |
BRD4 | N/A | Periodontitis | RAW264.7 cells | LPS | RELA | N/A | IL1B, IL6, TNF, TLR2, TLR4 | JQ1 |